Altimmune, Inc.
Nasdaq ALT · Gaithersburg, MD
Works in GI & liver · Infectious disease · Metabolic & endocrine · Psychiatry · Respiratory
Altimmune, Inc. is a clinical trial sponsor based in Gaithersburg, MD, listed as Nasdaq ALT. It has 2 active clinical trials with 1,921 planned participants, across 5 therapeutic areas. Since 2021 it has completed 15 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq ALT
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Altimmune, Inc
Altimmune, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 1,921 planned participants, in GI & liver, Infectious disease, Metabolic & endocrine, Psychiatry and other areas. Since 2021 it has completed 15 trials and stopped 2 early.
Altimmune, Inc is based in Gaithersburg, MD and is listed as Nasdaq ALT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Altimmune, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-23.
Approve Suite is not affiliated with Altimmune, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.